Article
18F-AlF-FAPI nanotracer visualized the quick response of sarcoma to radiotherapy by PET/CT
2023-07-14
Abstract excerpt
<title>Abstract</title> <p>Background MRI or CT-based RECIST is the current clinical standard for evaluating the efficacy of radiation therapy. Typically, several months are required after treatment to determine the extent of tumor control, with the possibility of malignant progression. In this study, we synthesize a novel nanoscale <sup>18</sup>F-AlF-labeled FAPI radiotracer and assess its capacity to monitor i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 52adf1cf-baca-59fa-bb8d-8f46a116df39
- DOI
- 10.21203/rs.3.rs-3113339/v1
